IMIDAZOLIDINE COMPOUNDS AND THEIR USE AS CXCR3 ANTAGONISTS

Details for Australian Patent Application No. 2002258919 (hide)

Owner MILLENNIUM PHARMACEUTICALS, INC. KYOWA HAKKO KOGYO., LTD.

Inventors KOMATSU, Rie; SONE, Hiroki; LULY, Jay, R.; LAROSA, Gregory, J.; KOTERA, Osamu

Pub. Number AU-A-2002258919

PCT Pub. Number WO2002/085861

Priority 09/838,551 19.04.01 US

Filing date 19 April 2002

Wipo publication date 5 November 2002

International Classifications

A61K 031/4164 - 1,3-Diazoles

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61P 043/00 Drugs for specific purposes, not provided for in groups

C07D 233/26 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002258919

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258920-ELECTRONIC ASSET ASSIGNMENT AND TRACKING

2002258918-DEMAND-BASED GOAL-DRIVEN SCHEDULING SYSTEM